Finance          Automotive          Computers          Health          Shopping          Sports         News          Reference           Print Facts in English - BCUZ.COMlos hechos en Español

AIDS



Main article: AIDS denialism

A small group of activists, including several scientists who do not study HIV/AIDS, question the connection between HIV and AIDS,[140] the existence of HIV itself,[141] or the validity of current testing and treatment methods. Though these claims have been examined and thoroughly rejected by the scientific community,[142] they continue to be promulgated through the Internet[143] and have had a significant political impact, particularly in South Africa, where President Thabo Mbeki's embrace of AIDS denialism has been blamed for an ineffective response to that country's AIDS epidemic.[144][145][146]

Notes and references

  1. ^ Weiss RA (May 1993). "How does HIV cause AIDS?". Science (journal) 260 (5112): 1273–9. PMID 8493571. 
  2. ^ Divisions of HIV/AIDS Prevention (2003). HIV and Its Transmission. Centers for Disease Control & Prevention. Retrieved on 2006-05-23.
  3. ^ San Francisco AIDS Foundation (2006-04-14). How HIV is spread. Retrieved on 2006-05-23.
  4. ^ a b c Kallings LO (2008). "The first postmodern pandemic: 25 years of HIV/AIDS". J Intern Med 263 (3): 218–43. doi:10.1111/j.1365-2796.2007.01910.x. PMID 18205765. 
  5. ^ a b c d e f g h UNAIDS, WHO (December 2007). 2007 AIDS epidemic update (PDF). Retrieved on 2008-03-12.
  6. ^ a b Bell C, Devarajan S, Gersbach H (2003). "The long-run economic costs of AIDS: theory and an application to South Africa" (PDF). World Bank Policy Research Working Paper No. 3152. Retrieved on 2008-04-28.
  7. ^ Gao F, Bailes E, Robertson DL, et al (1999). "Origin of HIV-1 in the Chimpanzee Pan troglodytes troglodytes". Nature 397 (6718): 436–441. doi:10.1038/17130. PMID 9989410. 
  8. ^ Gallo RC (2006). "A reflection on HIV/AIDS research after 25 years". Retrovirology 3: 72. doi:10.1186/1742-4690-3-72. PMID 17054781. 
  9. ^ a b Palella FJ Jr, Delaney KM, Moorman AC, et al (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators". N. Engl. J. Med 338 (13): 853–860. PMID 9516219. 
  10. ^ Holmes CB, Losina E, Walensky RP, Yazdanpanah Y, Freedberg KA (2003). "Review of human immunodeficiency virus type 1-related opportunistic infections in sub-Saharan Africa". Clin. Infect. Dis. 36 (5): 656–662. PMID 12594648. 
  11. ^ Guss DA (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1". J. Emerg. Med. 12 (3): 375–384. PMID 8040596. 
  12. ^ Guss DA (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 2". J. Emerg. Med. 12 (4): 491–497. PMID 7963396. 
  13. ^ Feldman C (2005). "Pneumonia associated with HIV infection". Curr. Opin. Infect. Dis. 18 (2): 165–170. PMID 15735422. 
  14. ^ Decker CF, Lazarus A (2000). "Tuberculosis and HIV infection. How to safely treat both disorders concurrently". Postgrad Med. 108 (2): 57–60, 65–68. PMID 10951746. 
  15. ^ Zaidi SA, Cervia JS (2002). "Diagnosis and management of infectious esophagitis associated with human immunodeficiency virus infection". J. Int. Assoc. Physicians AIDS Care (Chic Ill) 1 (2): 53–62. PMID 12942677. 
  16. ^ Pollok RC (2001). "Viruses causing diarrhoea in AIDS". Novartis Found. Symp. 238: 276–83; discussion 283–8. PMID 11444032. 
  17. ^ Guerrant RL, Hughes JM, Lima NL, Crane J (1990). "Diarrhea in developed and developing countries: magnitude, special settings, and etiologies". Rev. Infect. Dis. 12 (Suppl 1): S41–S50. PMID 2406855. 
  18. ^ Luft BJ, Chua A (2000). "Central Nervous System Toxoplasmosis in HIV Pathogenesis, Diagnosis, and Therapy". Curr. Infect. Dis. Rep. 2 (4): 358–362. PMID 11095878. 
  19. ^ Sadler M, Nelson MR (1997). "Progressive multifocal leukoencephalopathy in HIV". Int. J. STD AIDS 8 (6): 351–357. PMID 9179644. 
  20. ^ Gray F, Adle-Biassette H, Chrétien F, Lorin de la Grandmaison G, Force G, Keohane C (2001). "Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments". Clin. Neuropathol. 20 (4): 146–155. PMID 11495003. 
  21. ^ Grant I, Sacktor H, McArthur J (2005). "HIV neurocognitive disorders", in H. E. Gendelman, I. Grant, I. Everall, S. A. Lipton, and S. Swindells. (ed.): The Neurology of AIDS (PDF), 2nd, London, UK: Oxford University Press, 357–373. ISBN 0-19-852610-5. 
  22. ^ Satishchandra P, Nalini A, Gourie-Devi M, et al (2000). "Profile of neurologic disorders associated with HIV/AIDS from Bangalore, South India (1989–1996)". Indian J. Med. Res. 11: 14–23. PMID 10793489. 
  23. ^ Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, Nanivadekar A (2001). "Neurological manifestations of HIV disease". J. Assoc. Physicians India 49: 343–348. PMID 11291974. 
  24. ^ Boshoff C, Weiss R (2002). "AIDS-related malignancies". Nat. Rev. Cancer 2 (5): 373–382. PMID 12044013. 
  25. ^ Yarchoan R, Tosatom G, Littlem RF (2005). "Therapy insight: AIDS-related malignancies — the influence of antiviral therapy on pathogenesis and management". Nat. Clin. Pract. Oncol. 2 (8): 406–415. PMID 16130937. 
  26. ^ Palefsky J (2007). "Human papillomavirus infection in HIV-infected persons". Top HIV Med 15 (4): 130–3. PMID 17720998. 
  27. ^ Bonnet F, Lewden C, May T, et al (2004). "Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy". Cancer 101 (2): 317–324. PMID 15241829. 
  28. ^ Skoulidis F, Morgan MS, MacLeod KM (2004). "Penicillium marneffei: a pathogen on our doorstep?". J. R. Soc. Med. 97 (2): 394–396. PMID 15286196. 
  29. ^ Alimonti JB, Ball TB, Fowke KR (2003). "Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.". J. Gen. Virol. 84 (7): 1649–1661. doi:10.1099/vir.0.19110-0. PMID 12810858. 
  30. ^ (2003) An Atlas of Differential Diagnosis in HIV Disease, Second Edition. CRC Press-Parthenon Publishers, 22-27. ISBN 1-84214-026-4. 
  31. ^ a b c d e Morgan D, Mahe C, Mayanja B, Okongo JM, Lubega R, Whitworth JA (2002). "HIV-1 infection in rural Africa: is there a difference in median time to AIDS and survival compared with that in industrialized countries?". AIDS 16 (4): 597–632. PMID 11873003. 
  32. ^ a b Clerici M, Balotta C, Meroni L, et al (1996). "Type 1 cytokine production and low prevalence of viral isolation correlate with long-term non progression in HIV infection". AIDS Res. Hum. Retroviruses. 12 (11): 1053–1061. PMID 8827221. 
  33. ^ a b Morgan D, Mahe C, Mayanja B, Whitworth JA (2002). "Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study". BMJ 324 (7331): 193–196. doi:10.1136/bmj.324.7331.193. PMID 11809639. 
  34. ^ Gendelman HE, Phelps W, Feigenbaum L, et al (1986). "Transactivation of the human immunodeficiency virus long terminal repeat sequences by DNA viruses". Proc. Natl. Acad. Sci. U. S. A. 83 (24): 9759–9763. PMID 2432602. 
  35. ^ Bentwich Z, Kalinkovich, A, Weisman Z (1995). "Immune activation is a dominant factor in the pathogenesis of African AIDS.". Immunol. Today 16 (4): 187–191. PMID 7734046. 
  36. ^ a b Tang J, Kaslow RA (2003). "The impact of host genetics on HIV infection and disease progression in the era of highly active antiretroviral therapy". AIDS 17 (Suppl 4): S51–S60. PMID 15080180. 
  37. ^ Quiñones-Mateu ME, Mas A, Lain de Lera T, Soriano V, Alcami J, Lederman MM, Domingo E (1998). "LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression". Virus Research 57 (1): 11–20. PMID 9833881. 
  38. ^ a b Campbell GR, Pasquier E, Watkins J, et al (2004). "The glutamine-rich region of the HIV-1 Tat protein is involved in T-cell apoptosis". J. Biol. Chem. 279 (46): 48197–48204. doi:10.1074/jbc.M406195200. PMID 15331610. 
  39. ^ Kaleebu P, French N, Mahe C, et al (2002). "Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda". J. Infect. Dis. 185 (9): 1244–1250. PMID 12001041. 
  40. ^ Rothenberg RB, Scarlett M, del Rio C, Reznik D, O'Daniels C (1998). "Oral transmission of HIV". AIDS 12 (16): 2095–2105. PMID 9833850. 
  41. ^ Mastro TD, de Vincenzi I (1996). "Probabilities of sexual HIV-1 transmission". AIDS 10 (Suppl A): S75–S82. PMID 8883613. 
  42. ^ Koenig MA, Zablotska I, Lutalo T, Nalugoda F, Wagman J, Gray R (2004). "Coerced first intercourse and reproductive health among adolescent women in Rakai, Uganda". Int Fam Plan Perspect 30 (4): 156–63. doi:10.1363/ifpp.30.156.04. PMID 15590381. 
  43. ^ a b Laga M, Nzila N, Goeman J (1991). "The interrelationship of sexually transmitted diseases and HIV infection: implications for the control of both epidemics in Africa". AIDS 5 (Suppl 1): S55–S63. PMID 1669925. 
  44. ^ Tovanabutra S, Robison V, Wongtrakul J, et al (2002). "Male viral load and heterosexual transmission of HIV-1 subtype E in northern Thailand". J. Acquir. Immune. Defic. Syndr. 29 (3): 275–283. PMID 11873077. 
  45. ^ Sagar M, Lavreys L, Baeten JM, et al (2004). "Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population". AIDS 18 (4): 615–619. PMID 15090766. 
  46. ^ Lavreys L, Baeten JM, Martin HL, et al (March 2004). "Hormonal contraception and risk of HIV-1 acquisition: results of a 10-year prospective study". AIDS 18 (4): 695–7. PMID 15090778. 
  47. ^ Fan H (2005). in Fan, H., Conner, R. F. and Villarreal, L. P. eds: AIDS: science and society, 4th, Boston, MA: Jones and Bartlett Publishers. ISBN 0-7637-0086-X. 
  48. ^ WHO, UNAIDS Reaffirm HIV as a Sexually Transmitted Disease. WHO (2003-03-17). Retrieved on 2006-01-17.
  49. ^ Financial Resources Required to Achieve, Universal Access to HIV Prevention, Treatment Care and Support (pdf). UNAIDS. Retrieved on 2008-04-11.
  50. ^ Blood safety....for too few. WHO (2001). Retrieved on 2006-01-17.
  51. ^ a b Coovadia H (2004). "Antiretroviral agents—how best to protect infants from HIV and save their mothers from AIDS". N. Engl. J. Med. 351 (3): 289–292. PMID 15247337. 
  52. ^ Coovadia HM, Bland RM (2007). "Preserving breastfeeding practice through the HIV pandemic". Trop. Med. Int. Health. 12 (9): 1116–1133. PMID 17714431. 
  53. ^ Blechner MJ (1997). Hope and mortality: psychodynamic approaches to AIDS and HIV. Hillsdale, NJ: Analytic Press. ISBN 0-88163-223-6. 
  54. ^ Guss DA (1994). "The acquired immune deficiency syndrome: an overview for the emergency physician, Part 1". J Emerg Med 12 (3): 375–84. PMID 8040596. 
  55. ^ Hel Z, McGhee JR, Mestecky J (June 2006). "HIV infection: first battle decides the war". Trends Immunol. 27 (6): 274–81. doi:10.1016/j.it.2006.04.007. PMID 16679064. 
  56. ^ Mehandru S, Poles MA, Tenner-Racz K, Horowitz A, Hurley A, Hogan C, Boden D, Racz P, Markowitz M (September 2004). "Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract". J. Exp. Med. 200 (6): 761–70. doi:10.1084/jem.20041196. PMID 15365095. 
  57. ^ Brenchley JM, Schacker TW, Ruff LE, Price DA, Taylor JH, Beilman GJ, Nguyen PL, Khoruts A, Larson M, Haase AT, Douek DC (September 2004). "CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract". J. Exp. Med. 200 (6): 749–59. doi:10.1084/jem.20040874. PMID 15365096. 
  58. ^ Appay V, Sauce D (January 2008). "Immune activation and inflammation in HIV-1 infection: causes and consequences". J. Pathol. 214 (2): 231–41. doi:10.1002/path.2276. PMID 18161758. 
  59. ^ Brenchley JM, Price DA, Schacker TW, Asher TE, Silvestri G, Rao S, Kazzaz Z, Bornstein E, Lambotte O, Altmann D, Blazar BR, Rodriguez B, Teixeira-Johnson L, Landay A, Martin JN, Hecht FM, Picker LJ, Lederman MM, Deeks SG, Douek DC (December 2006). "Microbial translocation is a cause of systemic immune activation in chronic HIV infection". Nat. Med. 12 (12): 1365–71. doi:10.1038/nm1511. PMID 17115046. 
  60. ^ Textbook of Pathology by Harsh Mohan, ISBN 81-8061-368-2
  61. ^ Textbook of Pathology by Harsh Mohan, ISBN 81-8061-368-2
  62. ^ World Health Organization (1990). "Interim proposal for a WHO staging system for HIV infection and disease". WHO Wkly Epidem. Rec. 65 (29): 221–228. PMID 1974812. 
  63. ^ a b Centers for Disease Control (CDC) (1982). "Persistent, generalized lymphadenopathy among homosexual males.". MMWR Morb Mortal Wkly Rep. 31 (19): 249–251. PMID 6808340. 
  64. ^ a b Barré-Sinoussi F, Chermann JC, Rey F, et al (1983). "Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS)". Science 220 (4599): 868–871. doi:10.1126/science.6189183. PMID 6189183. 
  65. ^ 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. CDC (1992). Retrieved on 2006-02-09.
  66. ^ a b Kumaranayake L, Watts C (2001). "Resource allocation and priority setting of HIV/AIDS interventions: addressing the generalized epidemic in sub-Saharan Africa". J. Int. Dev. 13 (4): 451–466. doi:10.1002/jid.798. 
  67. ^ Weber B (2006). "Screening of HIV infection: role of molecular and immunological assays". Expert Rev. Mol. Diagn. 6 (3): 399–411. doi:10.1586/14737159.6.3.399. PMID 16706742. 
  68. ^ Tóth FD, Bácsi A, Beck Z, Szabó J (2001). "Vertical transmission of human immunodeficiency virus". Acta Microbiol Immunol Hung 48 (3-4): 413–27. doi:10.1556/AMicr.48.2001.3-4.10. PMID 11791341. 
  69. ^ Smith DK, Grohskopf LA, Black RJ, et al (2005). "Antiretroviral Postexposure Prophylaxis After Sexual, Injection-Drug Use, or Other Nonoccupational Exposure to HIV in the United States". MMWR 54 (RR02): 1–20. 
  70. ^ Donegan E, Stuart M, Niland JC, et al (1990). "Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations". Ann. Intern. Med. 113 (10): 733–739. PMID 2240875. 
  71. ^ Kaplan EH, Heimer R (1995). "HIV incidence among New Haven needle exchange participants: updated estimates from syringe tracking and testing data". J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10 (2): 175–176. PMID 7552482. 
  72. ^ Bell DM (1997). "Occupational risk of human immunodeficiency virus infection in healthcare workers: an overview.". Am. J. Med. 102 (5B): 9–15. PMID 9845490. 
  73. ^ a b c d European Study Group on Heterosexual Transmission of HIV (1992). "Comparison of female to male and male to female transmission of HIV in 563 stable couples". BMJ. 304 (6830): 809–813. PMID 1392708. 
  74. ^ a b c d e f Varghese B, Maher JE, Peterman TA, Branson BM,Steketee RW (2002). "Reducing the risk of sexual HIV transmission: quantifying the per-act risk for HIV on the basis of choice of partner, sex act, and condom use". Sex. Transm. Dis. 29 (1): 38–43. PMID 11773877. 
  75. ^ Leynaert B, Downs AM, de Vincenzi I (1998). "Heterosexual transmission of human immunodeficiency virus: variability of infectivity throughout the course of infection. European Study Group on Heterosexual Transmission of HIV". Am. J. Epidemiol. 148 (1): 88–96. PMID 9663408. 
  76. ^ Facts about AIDS & HIV. avert.org. Retrieved on 2007-11-30.
  77. ^ Johnson AM, Laga M (1988). "Heterosexual transmission of HIV". AIDS 2 (suppl. 1): S49-S56. PMID 3130121. 
  78. ^ N'Galy B, Ryder RW (1988). "Epidemiology of HIV infection in Africa". Journal of Acquired Immune Deficiency Syndromes 1 (6): 551-558. PMID 3225742. 
  79. ^ Deschamps MM, Pape JW, Hafner A, Johnson WD Jr. (1996). "Heterosexual transmission of HIV in Haiti". Annals of Internal Medicine 125 (4): 324–330. PMID 8678397. 
  80. ^ Cayley WE Jr. (2004). "Effectiveness of condoms in reducing heterosexual transmission of HIV". Am. Fam. Physician 70 (7): 1268–1269. PMID 15508535. 
  81. ^ Module 5/Guidelines for Educators (Microsoft Word). Durex. Retrieved on 2006-04-17.
  82. ^ PATH (2006). "The female condom: significant potential for STI and pregnancy prevention". Outlook 22 (2). 
  83. ^ Condom Facts and Figures. WHO (August 2003). Retrieved on 2006-01-17.
  84. ^ Dias SF, Matos MG, Goncalves, A. C. (2005). "Preventing HIV transmission in adolescents: an analysis of the Portuguese data from the Health Behaviour School-aged Children study and focus groups". Eur. J. Public Health 15 (3): 300–304. PMID 15941747. 
  85. ^ Weiss HA (February 2007). "Male circumcision as a preventive measure against HIV and other sexually transmitted diseases". Curr. Opin. Infect. Dis. 20 (1): 66–72. doi:10.1097/QCO.0b013e328011ab73. PMID 17197884. 
  86. ^ Eaton LA, Kalichman S (December 2007). "Risk compensation in HIV prevention: implications for vaccines, microbicides, and other biomedical HIV prevention technologies". Curr HIV/AIDS Rep 4 (4): 165–72. doi:10.1007/s11904-007-0024-7. PMID 18366947. 
  87. ^ Recommendations for Prevention of HIV Transmission in Health-Care Settings. Retrieved on 2008-04-28.
  88. ^ Kerr T, Kimber J, Debeck K, Wood E (December 2007). "The role of safer injection facilities in the response to HIV/AIDS among injection drug users". Curr HIV/AIDS Rep 4 (4): 158–64. doi:10.1007/s11904-007-0023-8. PMID 18366946. 
  89. ^ Wodak A, Cooney A (2006). "Do needle syringe programs reduce HIV infection among injecting drug users: a comprehensive review of the international evidence". Subst Use Misuse 41 (6-7): 777–813. doi:10.1080/10826080600669579. PMID 16809167. 
  90. ^ WHO HIV and Infant Feeding Technical Consultation (2006). Consensus statement (PDF). Retrieved on 2008-03-12.
  91. ^ Hamlyn E, Easterbrook P (August 2007). "Occupational exposure to HIV and the use of post-exposure prophylaxis". Occup Med (Lond) 57 (5): 329–36. doi:10.1093/occmed/kqm046. PMID 17656498. 
  92. ^ a b A Pocket Guide to Adult HIV/AIDS Treatment February 2006 edition. Department of Health and Human Services (February 2006). Retrieved on 2006-09-01.
  93. ^ A Pocket Guide to Adult HIV/AIDS Treatment February 2006 edition. Department of Health and Human Services (February 2006). Retrieved on 2006-09-01.
  94. ^ Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection (PDF). Department of Health and Human Services Working Group on Antiretroviral Therapy and Medical Management of HIV-Infected Children (2005-11-03). Retrieved on 2006-01-17.
  95. ^ Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents (PDF). Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV Infection (2005-10-06). Retrieved on 2006-01-17.
  96. ^ Martinez-Picado J, DePasquale MP, Kartsonis N, et al (2000). "Antiretroviral resistance during successful therapy of human immunodeficiency virus type 1 infection". Proc. Natl. Acad. Sci. U. S. A. 97 (20): 10948–10953. PMID 11005867. 
  97. ^ Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK; Panel on Clinical Practices for Treatment of HIV. (2002). "Guidelines for using antiretroviral agents among HIV-infected adults and adolescents". Ann. Intern. Med. 137 (5 Pt 2): 381–433. PMID 12617573. 
  98. ^ Blankson JN, Persaud D, Siliciano RF (2002). "The challenge of viral reservoirs in HIV-1 infection". Annu. Rev. Med. 53: 557–593. PMID 11818490. 
  99. ^ Palella FJ, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD (1998). "Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection". N. Engl. J. Med. 338 (13): 853–860. PMID 9516219. 
  100. ^ Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS (2003). "Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy?". AIDS 17 (5): 711–720. PMID 12646794. 
  101. ^ Chene G, Sterne JA, May M, Costagliola D, Ledergerber B, Phillips AN, Dabis F, Lundgren J, D'Arminio Monforte A, de Wolf F, Hogg R, Reiss P, Justice A, Leport C, Staszewski S, Gill J, Fatkenheuer G, Egger ME and the Antiretroviral Therapy Cohort Collaboration (2003). "Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies". Lancet 362 (9385): 679–686. doi:10.1016/S0140-6736(03)14229-8. PMID 12957089. 
  102. ^ King JT, Justice AC, Roberts MS, Chang CH, Fusco JS and the CHORUS Program Team (2003). "Long-Term HIV/AIDS Survival Estimation in the Highly Active Antiretroviral Therapy Era". Medical Decision Making 23 (1): 9–20. PMID 12583451. 
  103. ^ Tassie JM, Grabar S, Lancar R, Deloumeaux J, Bentata M, Costagliola D and the Clinical Epidemiology Group from the French Hospital Database on HIV (2002). "Time to AIDS from 1992 to 1999 in HIV-1-infected subjects with known date of infection". Journal of acquired immune deficiency syndromes 30 (1): 81–7. PMID 12048367. 
  104. ^ Becker SL, Dezii CM, Burtcel B, Kawabata H, Hodder S. (2002). "Young HIV-infected adults are at greater risk for medication nonadherence". MedGenMed. 4 (3): 21. PMID 12466764. 
  105. ^ Nieuwkerk P, Sprangers M, Burger D, Hoetelmans RM, Hugen PW, Danner SA, van Der Ende ME, Schneider MM, Schrey G, Meenhorst PL, Sprenger HG, Kauffmann RH, Jambroes M, Chesney MA, de Wolf F, Lange JM and the ATHENA Project (2001). "Limited Patient Adherence to Highly Active Antiretroviral Therapy for HIV-1 Infection in an Observational Cohort Study". Arch. Intern. Med. 161 (16): 1962–1968. PMID 11525698. 
  106. ^ Kleeberger C, Phair J, Strathdee S, Detels R, Kingsley L, Jacobson LP (2001). "Determinants of Heterogeneous Adherence to HIV-Antiretroviral Therapies in the Multicenter AIDS Cohort Study". J. Acquir. Immune Defic. Syndr. 26 (1): 82–92. PMID 11176272. 
  107. ^ Heath KV, Singer J, O'Shaughnessy MV, Montaner JS, Hogg RS (2002). "Intentional Nonadherence Due to Adverse Symptoms Associated With Antiretroviral Therapy". J. Acquir. Immune Defic. Syndr. 31 (2): 211–217. PMID 12394800. 
  108. ^ Burgoyne RW, Tan DH (March 2008). "Prolongation and quality of life for HIV-infected adults treated with highly active antiretroviral therapy (HAART): a balancing act". J. Antimicrob. Chemother. 61 (3): 469–73. doi:10.1093/jac/dkm499. PMID 18174196. 
  109. ^ Karlsson Hedestam GB, Fouchier RA, Phogat S, Burton DR, Sodroski J, Wyatt RT (February 2008). "The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus". Nat. Rev. Microbiol. 6 (2): 143–55. doi:10.1038/nrmicro1819. PMID 18197170. 
  110. ^ Laurence J (2006). "Hepatitis A and B virus immunization in HIV-infected persons". AIDS Reader 16 (1): 15–17. PMID 16433468. 
  111. ^ a b Power R, Gore-Felton C, Vosvick M, Israelski DM, Spiegel D (June 2002). "HIV: effectiveness of complementary and alternative medicine". Prim. Care 29 (2): 361–78. PMID 12391716. 
  112. ^ Nicholas PK, Kemppainen JK, Canaval GE, et al (February 2007). "Symptom management and self-care for peripheral neuropathy in HIV/AIDS". AIDS Care 19 (2): 179–89. doi:10.1080/09540120600971083. PMID 17364396. 
  113. ^ Liu JP, Manheimer E, Yang M (2005). "Herbal medicines for treating HIV infection and AIDS". Cochrane Database Syst Rev (3): CD003937. doi:10.1002/14651858.CD003937.pub2. PMID 16034917. 
  114. ^ a b Irlam JH, Visser ME, Rollins N, Siegfried N (2005). "Micronutrient supplementation in children and adults with HIV infection". Cochrane Database Syst Rev (4): CD003650. doi:10.1002/14651858.CD003650.pub2. PMID 16235333. 
  115. ^ Hurwitz BE, Klaus JR, Llabre MM, et al (January 2007). "Suppression of human immunodeficiency virus type 1 viral load with selenium supplementation: a randomized controlled trial". Arch. Intern. Med. 167 (2): 148–54. doi:10.1001/archinte.167.2.148. PMID 17242315. 
  116. ^ McNeil DG Jr. "U.N. agency to say it overstated extent of H.I.V. cases by millions", New York Times, 2007-11-20. Retrieved on 2008-03-18. 
  117. ^ Zwahlen M, Egger M (2006). "Progression and mortality of untreated HIV-positive individuals living in resource-limited settings: update of literature review and evidence synthesis" (PDF). UNAIDS Obligation HQ/05/422204. Retrieved on 2008-03-19.
  118. ^ Knoll B, Lassmann B, Temesgen Z (2007). "Current status of HIV infection: a review for non-HIV-treating physicians". Int J Dermatol 46 (12): 1219–28. doi:10.1111/j.1365-4632.2007.03520.x. PMID 18173512. 
  119. ^ a b Lawn SD (2004). "AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection". J. Infect. Dis. 48 (1): 1–12. PMID 14667787. 
  120. ^ Campbell GR, Watkins JD, Esquieu D, Pasquier E, Loret EP, Spector SA (2005). "The C terminus of HIV-1 Tat modulates the extent of CD178-mediated apoptosis of T cells". J. Biol. Chem. 280 (46): 38376–39382. PMID 16155003. 
  121. ^ Senkaali D, Muwonge R, Morgan D, Yirrell D, Whitworth J, Kaleebu P (2005). "The relationship between HIV type 1 disease progression and V3 serotype in a rural Ugandan cohort". AIDS Res. Hum. Retroviruses. 20 (9): 932–937. PMID 15585080. 
  122. ^ Gottlieb MS (2006). "Pneumocystis pneumonia--Los Angeles. 1981". Am J Public Health 96 (6): 980–1; discussion 982–3. PMID 16714472. 
  123. ^ a b Centers for Disease Control (CDC) (1982). "Opportunistic infections and Kaposi's sarcoma among Haitians in the United States". MMWR Morb Mortal Wkly Rep. 31 (26): 353–354; 360–361. PMID 6811853. 
  124. ^ Altman LK. "New homosexual disorder worries officials", The New York Times, 1982-05-11. 
  125. ^ Kher U. "A Name for the Plague", Time, 1982-07-27. Retrieved on 2008-03-10. 
  126. ^ Centers for Disease Control (CDC) (1982). "Update on acquired immune deficiency syndrome (AIDS)—United States.". MMWR Morb Mortal Wkly Rep. 31 (37): 507–508; 513–514. PMID 6815471. 
  127. ^ Curtis T. "The origin of AIDS", Rolling Stone, pp. 54–59, 61, 106, 108. Retrieved on 2008-03-10. 
  128. ^ Hooper E (1999). The River : A Journey to the Source of HIV and AIDS, 1st, Boston, MA: Little Brown & Co, 1–1070. ISBN 0-316-37261-7. 
  129. ^ Worobey M, Santiago ML, Keele BF, et al (2004). "Origin of AIDS: contaminated polio vaccine theory refuted". Nature 428 (6985): 820. doi:10.1038/428820a. PMID 15103367. 
  130. ^ Berry N, Jenkins A, Martin J, et al (2005). "Mitochondrial DNA and retroviral RNA analyses of archival oral polio vaccine (OPV CHAT) materials: evidence of macaque nuclear sequences confirms substrate identity". Vaccine 23: 1639–1648. doi:10.1016/j.vaccine.2004.10.038. PMID 15705467. 
  131. ^ Oral Polio Vaccine and HIV / AIDS: Questions and Answers. Centers for Disease Control and Prevention (2004-03-23). Retrieved on 2006-11-20.
  132. ^ Gilbert MT, Rambaut A, Wlasiuk G, Spira TJ, Pitchenik AE, Worobey M (2007). "The emergence of HIV/AIDS in the Americas and beyond". Proc. Natl. Acad. Sci. U.S.A. 104 (47): 18566–70. doi:10.1073/pnas.0705329104. PMID 17978186. 
  133. ^ (2006) "The impact of AIDS on people and societies", 2006 Report on the global AIDS epidemic (PDF), UNAIDS. Retrieved on 2006-06-14. 
  134. ^ Ogden J, Nyblade L (2005). Common at its core: HIV-related stigma across contexts (PDF). International Center for Research on Women. Retrieved on 2007-02-15.
  135. ^ a b c Herek GM, Capitanio JP (1999). "AIDS Stigma and sexual prejudice" (PDF). American Behavioral Scientist 42 (7): 1130-1147. doi:10.1177/0002764299042007006. 
  136. ^ Snyder M, Omoto AM, Crain AL (1999). "Punished for their good deeds: stigmatization for AIDS volunteers". American Behavioral Scientist 42 (7): 1175–1192. doi:10.1177/0002764299042007009. 
  137. ^ Herek GM, Capitanio JP, Widaman KF (2002). "HIV-related stigma and knowledge in the United States: prevalence and trends, 1991-1999". Am J Public Health 92 (3): 371–7. PMID 11867313. 
  138. ^ a b Greener R (2002). "AIDS and macroeconomic impact", in S, Forsyth (ed.): State of The Art: AIDS and Economics. IAEN, 49–55. 
  139. ^ Over M (1992). "The macroeconomic impact of AIDS in Sub-Saharan Africa, Population and Human Resources Department" (PDF). . The World Bank Retrieved on 2008-05-03.
  140. ^ Duesberg PH (1988). "HIV is not the cause of AIDS". Science 241 (4865): 514, 517. doi:10.1126/science.3399880. PMID 3399880. 
  141. ^ Papadopulos-Eleopulos E, Turner VF, Papadimitriou J, et al (2004). "A critique of the Montagnier evidence for the HIV/AIDS hypothesis". Med Hypotheses 63 (4): 597–601. doi:10.1016/j.mehy.2004.03.025. PMID 15325002. 
  142. ^ For evidence of the scientific consensus that HIV is the cause of AIDS, see (for example):
  143. ^ Smith TC, Novella SP (2007). "HIV denial in the Internet era". PLoS Med. 4 (8): e256. doi:10.1371/journal.pmed.0040256. PMID 17713982. 
  144. ^ Watson J (2006). "Scientists, activists sue South Africa's AIDS 'denialists'". Nat. Med. 12 (1): 6. doi:10.1038/nm0106-6a. PMID 16397537. 
  145. ^ Baleta A (2003). "S Africa's AIDS activists accuse government of murder". Lancet 361 (9363): 1105. doi:10.1016/S0140-6736(03)12909-1. PMID 12672319. 
  146. ^ Cohen J (2000). "South Africa's new enemy". Science 288 (5474): 2168–70. doi:10.1126/science.288.5474.2168. PMID 10896606. 

Further reading

External links

Find more about AIDS on Wikipedia's sister projects:
Dictionary definitions
Textbooks
Quotations
Source texts
Images and media
News stories
Learning resources
v • d • e
HIV/AIDS related topics
HIV
History
Culture
AIDS pandemic in
Denialism
v • d • e
Sexually transmitted diseases and infections (STD/STI) (primarily A50-A64, 090-099)
Bacterial
Protozoal
Parasitic
Viral
Other conditions




BCUZ.com FACTS Encyclopedia content is licensed under the GFDL as approved by Wikipedia.
For more information review our copyright contact and privacy policy.
© 1996 - BCUZ.COM - We have all the FACTS you need about Small Business Financing, Behavior Disorder, Having Too Many Bills, Needing Cash Fast, Structured Settlements, Frequent Flier Programs, Top Steak Houses, The Mayan Indians, Norfolk and Suffolk England, Growing Longer Hair and a full reference English Encyclopedia and Spanish Encyclopedia.Privacy Policy